Answers are grounded in this paper and cite their sources.
SUMMARY BACKGROUND Pulmonary tuberculosis (TB) is the leading infectious cause of death globally, and it is estimated that half of TB survivors develop post-TB lung disease (PTLD). Given limited prospective data, we evaluated the prevalence, lung function, risk factors, and quality of life (QoL) of PTLD in a Ugandan cohort. METHODS Adults with pulmonary TB were enrolled from Ugandan referral hospitals. Socio-demographic characteristics, exposures, QoL, chest radiography (CXR), and TB care variables were collected at enrolment. Post-TB treatment and 1-year follow-up visits included repeat CXR, pulmonary function testing (PFT), and questionnaires. PTLD was defined as post-treatment DLCO <80%, total lung capacity <80%, or post-bronchodilator FEV1/FVC z-score <−1.64 using Global Lung Function Initiative reference equations. Multivariable logistic regression evaluated factors associated with PTLD. RESULTS Of 109 participants who completed post-TB treatment follow-up, 40% met PFT criteria for PTLD. In adjusted analyses, lower body mass index (BMI), barriers to TB care, and high-risk pulmonary exposures were associated with PTLD. Participants with PTLD had greater radiographic disease burden and higher St. George’s Respiratory Questionnaire scores at end of treatment. Lung function improved over 1 year among PTLD participants. CONCLUSIONS Among Uganda TB survivors, functional lung impairment was high and 40% had PTLD. Modifiable risk factors, including BMI, TB care, and respiratory exposures, highlight opportunities for intervention.
No takes yet. Share an insight, caveat, or question.
Helwig et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: